SaVi Media Group, Inc. SVMI
Convenience TV Inc. CRPZ
THQ, Inc. THQI
BioSante Pharmaceuticals, Inc. BPAX
_
_
BPAX pushed to a new high on Wednesday, breaking resistance, and hit .75, before closing at .6719. We are going to monitoring closely as the company approaches its FDA date next month. A positive FDA decision on BPAX’s Bio-T-Gel could be a serious catalyst for more growth in the stock.
Last week, we added SAPX to our radar, and since then it has been trading sideways in a tight channel, seeing little movement in either direction. We want to keep this stock on our radar, waiting to see a pickup in volume which would likely result in a nice PPS increase.
NSRS exploded yesterday, closing at .825. From our original alert at .253 on Dec.28th, that’s a 232% gain! The stock has been rising steadily over that time, with an extra boost provided by Tuesday’s PR outlining a new LOI:
LAS VEGAS, NEVADA, Jan 17, 2012 (MARKETWIRE via COMTEX) — North Springs Resources Corp. (OTCBB: NSRS)(PINKSHEETS: NSRS) (the “Company” or “North Springs”) is pleased to provide this further update regarding the recently announced Letter of Intent (“LOI”) with Discovery Gold Ghana Limited (“Discovery Gold”) to acquire a ten percent (10%) interest in the Edum Banso Gold Project (“Edum Banso”), a high-potential gold exploration property in Ghana, Africa.
This blast from the past did very well for us midway through 2011, and has had a couple of nice bounces as its come down to touch bottom. .0009 and .0011 are our levels of support that we should watch closely; if those levels are lost, things could get ugly fast, but in the meantime, we are treating ICPA as a bottom play with bounce potential. Key resistance points are .003 and .0042.
ICPA was a spotlight on StockTradersTalk radio last night. For those of you that have not checked out the STT, feel encouraged to do so, as the show provides some really good insights into the world of trading for both beginning and experience traders alike. Check it out at StockTradersTalk.com
You’ve heard us say, “if it ain’t broke, don’t fix it”. BPAX broke its resistance on Tuesday, hitting a HOD of .6749, closing the day at .66, and kicking off this short week in good fashion. So far, our total gains on BPAX are sitting at 74%
There are certain groups who believe wrongdoing was taking place with regard to the statements released by the company about its failed product, LibiGel. We are reserving judgement until more information comes to light, but thought you should be made aware of the situation as well.
NEW YORK, Jan 11, 2012 (BUSINESS WIRE) — Levi & Korsinsky is investigating potential claims on behalf of purchasers of BioSante Pharmaceuticals, Inc. (“BioSante” or the “Company”) (Nasdaq: BPAX) securities concerning possible violations of federal securities laws.
For more information, click here: http://zlk.9nl.com/biosante-pharmaceuticals-bpax.
ATRN saw a modest 5% increase yesterday, on lighter-than-average volume. It is good to see a consolidation and sideways trading action on decreased volume; it appears as if ATRN is building a new base for its next leg up.
The RSI still appears oversold, and has plenty of room to climb higher from here
TRID had its first down day Tuesday since we’ve been following this stock. After 125% in gains, a little pullback is to be expected, but we wont let the symbol slip from our radar just yet. The stock maintained a higher low of .127, only to close at .143, for a 13% intraday gain.
This stock hit its 52-week low yesterday, so we are going to be watching closely for signs that its hit its bottom, that we might catch it on the rebound.
Just as recently as October, VSST was trading in the .70-.80 range, and between 1.25-1.50 back in August. Should the stock recover from this selloff and return to those previous prices, gains of 250%-600% could be in store.
This all may not happen overnight, thus we would categorize this as a long term play. As you’ve seen with our other bottom plays, its always best to begin paying attention early, so as not to miss a beat when the stock begins to turn up from its bottom.
We think that this company has a great technology that could eventually take off, but don’t take our word for it: The company offers free 30-day trials here.